The Efficacy and Safety of a Qiliqiangxin Capsule Combined with Sacubitril/Valsartan in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis

BACKGROUND: Qiliqiangxin (QLQX) capsules are a commonly used proprietary Chinese medicine for the adjuvant treatment of chronic heart failure (CHF) in China. In recent years, several randomized controlled trials (RCTs) have reported on the efficacy and safety of QLQX combined with sacubitril/valsart...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wensheng, Chang, Huihua, Wang, Xiaoqi, Wang, Yuanping, Liu, Yuntao, Wang, Dawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918363/
https://www.ncbi.nlm.nih.gov/pubmed/36777628
http://dx.doi.org/10.1155/2023/2701314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918363/
https://www.ncbi.nlm.nih.gov/pubmed/36777628
http://dx.doi.org/10.1155/2023/2701314

Ejemplares similares